Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Show more...
FAQ
Silence Therapeutics 今天的股價是多少?▼
SLN 目前價格為 $14.65 USD,過去 24 小時下跌了 -0.98%。在圖表上更密切關注 Silence Therapeutics 股票的表現。
Silence Therapeutics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 XNAS 交易所,Silence Therapeutics 的股票以代號 SLN 進行交易。
Silence Therapeutics 的股價在上漲嗎?▼
SLN 股票較上週上漲 +9.13%,本月上漲 +31.11%,過去一年 Silence Therapeutics 上漲 +180.02%。
Silence Therapeutics 的市值是多少?▼
今天 Silence Therapeutics 的市值為 910.25M
Silence Therapeutics 上一季度的財報如何?▼
SLN 上一季度的財報為每股 -0.27 USD,預估為 -0.43 USD,帶來 +37.21% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Silence Therapeutics 去年的營收是多少?▼
Silence Therapeutics 去年的營收為 559,000USD。
Silence Therapeutics 去年的淨利是多少?▼
SLN 去年的淨收益為 -88.61MUSD。
Silence Therapeutics 有多少名員工?▼
截至 September 04, 2026,公司共有 88 名員工。
Silence Therapeutics 位於哪個產業?▼
Silence Therapeutics從事於Health & Wellness產業。
Silence Therapeutics 何時完成拆股?▼
Silence Therapeutics 最近沒有進行任何拆股。
Silence Therapeutics 的總部在哪裡?▼
Silence Therapeutics 的總部位於 英國 的 LONDON。